Search bioRxiv⌕ Search

Biology subjects

Wang, Y. E.

Publications and source records attributed to Wang, Y. E..

5 recordsLinked to original sources

LinkLlama: Enabling Large Language Model for Chemically Reasonable Linker Design

Fragment-based drug discovery (FBDD) relies heavily on the design of chemically viable linkers to connect fragments binding to different pocket regions into potent lead molecules. While recent generative models have advanced spatial fragment linking, they frequently produce linkers characterized by high torsional strain and non-drug-like motifs. In this work, we present LinkLlama, a fine-tuned Meta Llama 3 model that bridges the gap between text-based generation and 3D spatial awareness. By accepting natural language prompts that specify geometric constraints, such as distances and angles, alongside physicochemical targets like Lipinskis rules and rotatable bond limits, LinkLlama generates highly tailored molecules for the input fragments. Leveraging the inherent chemical grammar captured through supervised fine-tuning on a curated corpus of drug-like molecules from ChEMBL, the model prioritizes chemical validity without requiring complex reinforcement learning loops. Benchmarking on the ZINC and HiQBind datasets demonstrates that LinkLlama maintains competitive geometric fidelity compared to strictly 3D-aware models while achieving a two-fold increase in the proportion of chemically reasonable designs. This rising success rate, jumping from 35% to over 80%, is defined by strict adherence to comprehensive structural filters including PAINS, non-drug-like chemical patterns and complex ring systems. We further illustrate the models versatility through prospective case studies in novel small-molecule scaffold hopping and PROTAC linker design, validated via molecular docking and molecular dynamics simulations against known crystal poses. Ultimately, LinkLlama demonstrates that large language models can overcome the structural pitfalls of purely 3D-generative methods, offering a highly controllable and chemically robust framework to accelerate linker design and drug discovery in general.

bioinformatics↗

Integrative Multi-Omics Analysis Identifies a Functional Enhancer Driving Tumorigenesis in Head and Neck Squamous Cell Carcinoma

Enhancer is a critical epigenetic feature in head and neck squamous cell carcinoma (HNSCC), yet the functional roles of individual enhancers remain poorly understood. Here, we conducted an integrative multi-omics analysis based on publicly available ATAC-seq, H3K27ac ChIP-seq, transcriptomic profiling, and genetic association datasets to systematically map HNSCC-associated enhancers and their target genes. Integrating ATAC-seq and H3K27ac ChIP-seq, we identified 20,362 enhancers and 18,040 enhancer-associated genes, highlighting widespread regulatory complexity. Functional characterization of the TERT-associated enhancer GH05J001312 (GRCh38/hg38: chr5:1312099-1317743) revealed strong transcriptional activity in HNSCC. CRISPR-mediated deletion of a core sequence significantly reduced TERT expression, impaired cellular proliferation in vitro, and suppressed tumor growth in vivo, confirming its role as a key cis-regulatory element. RNA-seq analysis of enhancer-edited cells uncovered 742 differentially expressed genes enriched in cancer-related pathways, including MAPK and IL-17 signaling, indicating a broad transcriptional impact. Collectively, our findings establish GH05J001312 as a functional enhancer driving oncogenic programs in HNSCC and suggest enhancer-targeted strategies as a potential therapeutic avenue.

cancer biology↗

The genetic driver of Acute Necrotizing Encephalopathy, RANBP2, regulates the inflammatory response to Influenza A virus infection

Influenza virus infections can cause severe complications such as Acute Necrotizing Encephalopathy (ANE), which is characterised by rapid onset pathological inflammation following febrile infection. Heterozygous dominant mutations in the nucleoporin RANBP2/Nup358 predispose to influenza-triggered ANE1. The aim of our study was to determine whether RANBP2 plays a role in IAV-triggered inflammatory responses. We found that the depletion of RANBP2 in a human airway epithelial cell line increased IAV genomic replication by favouring the import of the viral polymerase subunits, PB1, PB2 and PA following viral transcription and translation. Additionally, RANBP2 knockdown enhanced the cytoplasmic export of viral RNA (vRNA) and disrupted segment stoichiometry, which associated with elevated production of the pro-inflammatory chemokines CXCL8, CXCL10, CCL2, CCL3 and CCL4 in human primary macrophages. Using CRISPR-Cas9 knock-in for the ANE1 disease variant RANBP2-T585M, we further demonstrate that this point mutation causes a loss-of-localisation phenotype that excludes RANBP2 from the nuclear envelope, which phenocopies RANBP2 knockdown by increasing IAV replication and driving pro-inflammatory cytokine expression following infection. Together, our results reveal that RANBP2 regulates influenza RNA replication and nuclear export, thereby restraining virus-induced hyperinflammation, and further suggest that ANE1 pathogenesis results from the impaired localisation of RANBP2 at the nuclear envelope.

immunology↗

RanBP2/Nup358 enhances RNAi activity by sumoylating and stabilizing Argonaute 1

RanBP2/Nup358 is one of the main components of the cytoplasmic filaments of the nuclear pore complex. It has been speculated that RanBP2, which has an E3 SUMO-ligase domain, may alter the composition of messenger ribonucleoprotein (mRNP) complexes as they emerge from the nuclear pore and thus regulate the ultimate fate of the mRNA in the cytoplasm. Four separate missense mutations in RanBP2 cause Acute Necrotizing Encephalopathy 1 (ANE1), which manifests as a sharp rise in cytokine production after common viral infections such as influenza and parainfluenza. However, how RanBP2 and its ANE1-associated mutations affect cytokine production is not well understood. Here we report that RanBP2 represses the translation of the interleukin-6 (IL6) mRNA, which encodes a cytokine that is aberrantly up-regulated in ANE1. Our data indicates that soon after its production, the IL6 mRNP recruits the RNA-induced silencing complex (RISC) bound to Let7 miRNA. After this mRNP is exported, RanBP2 sumoylates the RISC-component AGO1, thereby stabilizing it and enforcing mRNA silencing. Collectively, these results support a model whereby RanBP2 promotes an mRNP remodelling event that is critical for the miRNA-mediated suppression of clinically relevant mRNAs, such as IL6.

molecular biology↗

WebMeV: A Cloud Platform for Analyzing and Visualizing Cancer Genomic Data

Although large, complex genomic data sets are increasingly easy to generate, and the number of publicly available data sets in cancer and other diseases is rapidly growing, the lack of intuitive, easy to use analysis tools has remained a barrier to the effective use of such data. WebMeV (https://mev.tm4.org) is an open-source, web-based tool that gives users access to sophisticated tools for analysis of RNA-Seq and other data in an interface designed to democratize data access. WebMeV combines cloud-based technologies with a simple user interface to allow users to access large public data sets such as that from The Cancer Genome Atlas (TCGA) or to upload their own. The interface allows users to visualize data and to apply advanced data mining analysis methods to explore the data and draw biologically meaningful conclusions. We provide an overview of WebMeV and demonstrate two simple use cases that illustrate the value of putting data analysis in the hands of those looking to explore the underlying biology of the systems being studied.

bioinformatics↗